News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
32,434 Results
Type
Article (3443)
Company Profile (16)
Press Release (28975)
Section
Business (7409)
Career Advice (582)
Deals (1512)
Drug Delivery (24)
Drug Development (4572)
Employer Resources (37)
FDA (804)
Job Trends (1262)
News (14673)
Policy (1579)
Tag
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (217)
Accelerated approval (2)
Adcomms (2)
Allergies (21)
Alliances (1778)
ALS (3)
Alzheimer's disease (72)
Antibody-drug conjugate (ADC) (11)
Approvals (806)
Artificial intelligence (26)
Autoimmune disease (2)
Bankruptcy (14)
Best Places to Work (1121)
BIOSECURE Act (1)
Biosimilars (9)
Biotechnology (14)
Bladder cancer (5)
Brain cancer (1)
Breast cancer (17)
Cancer (202)
Cardiovascular disease (18)
Career advice (488)
Career pathing (13)
CAR-T (13)
Cell therapy (42)
Cervical cancer (1)
Clinical research (3676)
Collaboration (46)
Compensation (3)
COVID-19 (211)
CRISPR (2)
C-suite (14)
Cystic fibrosis (4)
Data (184)
Decentralized trials (1)
Denatured (2)
Depression (5)
Diabetes (24)
Diagnostics (300)
Digital health (2)
Diversity (3)
Diversity, equity & inclusion (12)
Drug discovery (16)
Drug pricing (19)
Drug shortages (4)
Duchenne muscular dystrophy (7)
Earnings (3184)
Editorial (11)
Employer branding (8)
Employer resources (36)
Events (4155)
Executive appointments (23)
FDA (908)
Featured Employer (7)
Friedreich's ataxia (1)
Funding (47)
Gene editing (7)
Generative AI (5)
Gene therapy (32)
GLP-1 (60)
Government (274)
Guidances (4)
Healthcare (1166)
Huntington's disease (3)
IgA nephropathy (1)
Immunology and inflammation (14)
Indications (7)
Infectious disease (231)
Inflammatory bowel disease (7)
Inflation Reduction Act (7)
Influenza (8)
Intellectual property (9)
Interviews (119)
IPO (827)
IRA (10)
Job creations (182)
Job search strategy (401)
Kidney cancer (1)
Labor market (20)
Layoffs (34)
Leadership (8)
Legal (286)
Liver cancer (15)
Lung cancer (32)
Lymphoma (16)
Management (12)
Manufacturing (26)
MASH (6)
Medical device (520)
Medtech (520)
Mergers & acquisitions (725)
Metabolic disorders (62)
Multiple sclerosis (9)
Neurodegenerative disease (6)
Neuropsychiatric disorders (2)
Neuroscience (121)
NextGen: Class of 2025 (411)
Non-profit (385)
Northern California (152)
Now hiring (9)
Obesity (37)
Opinion (46)
Ovarian cancer (6)
Pain (3)
Pancreatic cancer (11)
Parkinson's disease (11)
Partnered (12)
Patents (14)
Patient recruitment (9)
Peanut (9)
People (2006)
Pharmaceutical (6)
Pharmacy benefit managers (2)
Phase I (1052)
Phase II (1538)
Phase III (1453)
Pipeline (89)
Policy (27)
Postmarket research (100)
Preclinical (458)
Press Release (2)
Prostate cancer (22)
Psychedelics (4)
Radiopharmaceuticals (18)
Rare diseases (27)
Real estate (147)
Recruiting (14)
Regulatory (1190)
Reports (24)
Research institute (156)
Resumes & cover letters (82)
RNA editing (1)
RSV (9)
Schizophrenia (12)
Series A (8)
Series B (1)
Sickle cell disease (1)
Southern California (149)
Special edition (15)
Spinal muscular atrophy (9)
Sponsored (3)
Startups (142)
Supply chain (7)
Tariffs (8)
The Weekly (2)
United States (1234)
Vaccines (67)
Venture capitalists (11)
Weight loss (30)
Women's health (2)
Worklife (7)
Date
Today (2)
Last 7 days (28)
Last 30 days (164)
Last 365 days (2676)
2025 (801)
2024 (2523)
2023 (2176)
2022 (3168)
2021 (3389)
2020 (3051)
2019 (2894)
2018 (2072)
2017 (1626)
2016 (1651)
2015 (1600)
2014 (1069)
2013 (828)
2012 (887)
2011 (889)
2010 (714)
Location
Africa (117)
Arizona (8)
Arkansas (2)
Asia (2464)
Australia (416)
California (341)
Canada (101)
China (60)
Colorado (9)
Connecticut (31)
Delaware (13)
Europe (4555)
Florida (70)
Georgia (15)
Idaho (4)
Illinois (64)
India (2)
Indiana (30)
Iowa (1)
Japan (12)
Kansas (3)
Kentucky (1)
Maryland (75)
Massachusetts (165)
Michigan (6)
Minnesota (22)
Missouri (1)
Montana (3)
Nebraska (1)
Nevada (2)
New Jersey (112)
New Mexico (1)
New York (92)
North Carolina (52)
North Dakota (1)
Northern California (152)
Ohio (10)
Oregon (3)
Pennsylvania (86)
Rhode Island (4)
South America (129)
Southern California (149)
Tennessee (5)
Texas (17)
Utah (6)
Virginia (5)
Washington D.C. (8)
Washington State (31)
West Virginia (1)
Wisconsin (4)
32,434 Results for "ars".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
ARS Wins FDA Approval for Neffy Spray for Children in Anaphylaxis
Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 years, according to ARS Pharmaceuticals.
March 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial
April 1, 2025
·
3 min read
Press Releases
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 20, 2025
·
17 min read
Press Releases
ARS Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Conference
February 5, 2025
·
1 min read
Approvals
ARS Pharma Gets FDA Green Light for First Nasal Spray for Severe Allergic Reactions
ARS Pharma’s neffy on Friday became the first FDA-approved nasal spray to address severe allergic reactions, including those that might lead to life-threatening anaphylaxis.
August 12, 2024
·
2 min read
·
Tristan Manalac
Press Releases
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences
March 3, 2025
·
1 min read
Press Releases
Arthrosi Announces First Patient Dosed in Replicate Pivotal Phase 3 REDUCE 1 Trial of Lead Compound AR882
March 18, 2025
·
2 min read
Press Releases
ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia
December 13, 2024
·
8 min read
Press Releases
Arthrosi Therapeutics Completes Enrollment in Pivotal Phase 3 REDUCE 2 Trial of AR882 for the Treatment of Gout and Tophaceous Gout
March 5, 2025
·
2 min read
Press Releases
ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
·
1 min read
1 of 3,244
Next
